Publications Print Callister MN, Klanderman MC, Stockard A, Van Der Walt C, Pena AB, Caviness JN. Clinical Utility of Neurophysiologic Classification (and Declassification) of Myoclonus. Mov Disord. 2024 Oct 14 [Epub ahead of print] View PubMed Middlebrooks EH, Okromelidze L, Carter RE, Jain A, Lin C, Westerhold E, Pena AB, Quinones-Hinojosa A, Uitti RJ, Grewal SS. Directed stimulation of the dentato-rubro-thalamic tract for deep brain stimulation in essential tremor: a blinded clinical trial. Neuroradiol J. 2022 Apr; 35 (2):203-212 Epub 2021 Aug 02 View PubMed Koike Y, Jansen-West KR, Hanna Al-Shaikh R, Carlomagno Y, Song Y, Dunmore JA, LeDoux MS, Friedman JH, Pena AB, Uitti RJ, Zaremba J, van Gerpen JA, Pfeiffer RF, Veerappan V, Aiba I, Hashimoto R, Giles SS, Shah JS, Tipton PW, Huang JF, Wierenga KJ, Aasly J, Fryer JD, Petrucelli L, Wszolek ZK, Prudencio M. Urine levels of the polyglutamine ataxin-3 protein are elevated in patients with spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2021 Aug; 89:151-154 Epub 2021 July 17 View PubMed Pena AB, Caviness JN. Physiology-Based Treatment of Myoclonus. Neurotherapeutics. 2020 Oct; 17 (4):1665-1680 View PubMed Pena AB. Botulinum toxin for cervical dystonia: addressing treatment failure and improving outcomes. Neurol Neurochir Pol. 2020; 54 (3):218-219 View PubMed Ferris DG, Waller J, Dickinson A, McCracken C, Goebel A. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance. J Low Genit Tract Dis. 2012 Jan; 16 (1):39-44 View PubMed PST-20466128 Home Publications